MIP
AMED

Marietta Investment Partners’s Amedisys AMED Stock Holding History

Marietta Investment Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,816
Closed -$7.06M – 180
2021
Q2 		$7.06M Buy
28,816
+84
+0.3% +$22K 1.61% 16
2021
Q1 		$7.61M Sell
28,732
-1,067
-4% -$301K 1.88% 14
2020
Q4 		$8.74M Buy
29,799
+3,614
+14% +$927K 2.23% 13
2020
Q3 		$6.19M Buy
26,185
+1,342
+5% +$305K 1.87% 16
2020
Q2 		$4.93M Buy
24,843
+730
+3% +$136K 1.64% 19
2020
Q1 		$4.43M Buy
24,113
+15,082
+167% +$2.68M 1.9% 16
2019
Q4 		$1.51M Buy
+9,031
New +$1.34M 0.49% 52

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marietta Investment Partners's AMED Position: Q3 2021 in Review

Marietta Investment Partners sold out of Amedisys (AMED) in Q3 2021, closing a stake of 28,816 shares — an estimated $7.06M sold.

Marietta Investment Partners first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $8.74M in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Marietta Investment Partners reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Marietta Investment Partners sold 28,816 Amedisys shares in Q3 2021, an estimated $7.06M.
  • Marietta Investment Partners first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
  • Marietta Investment Partners's Amedisys position peaked at $8.74M in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Marietta Investment Partners's 13F filing for Q3 2021, filed 9 Nov 2021.